Vivek Subbiah, MD
M.D. Anderson Cancer Center
7
7
6
N/A
0
8
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+8 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (7)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Jennifer Johnson, MD, PhD
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Shared therapeutic areas:
Worked with same sponsors:
Raymond Bergan, MD
OHSU Knight Cancer Institute
Shared therapeutic areas:
Worked with same sponsors:
Manish A Shah, MD
Weill Cornell Solid Tumor Oncology Practice
Shared therapeutic areas:
Worked with same sponsors:
Kim-Son Nguyen, MD
Palo Alto Medical Foundation
Shared therapeutic areas:
Worked with same sponsors:
Zhenfeng Zhang, MD, PhD
Second Affiliated Hospital of Guangzhou Medical University
Shared therapeutic areas:
Lin Shen, MD
Peking University Cancer Hospital & Institute
Shared therapeutic areas:
Aminah Jatoi, MD
Mayo Clinic
Shared therapeutic areas:
Mark Levine, MD
Ontario Clinical Oncology Group (OCOG)
Shared therapeutic areas:
Lizhi Niu, PhD
Fuda Cancer Hospital
Shared therapeutic areas:
lin shen
Peking University Cancer Hospital & Institute
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (7)
Showing 7 of 7 trials
The Registry of Oncology Outcomes Associated With Testing and Treatment
Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell Cancer
Regorafenib and Cetuximab in Patients With Advanced Malignancy
Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in Osteosarcoma
Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer
Trial of Curcumin in Advanced Pancreatic Cancer
BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors
All 7 trials loaded